Document
Advisory Committee on Immunization Practices (ACIP); Notice of Meeting and Request for Comment
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open t...
SUPPLEMENTARY INFORMATION:
Purpose:
The committee is charged with advising the Director, CDC, on the use of immunizing agents. In addition, under 
42 U.S.C. 1396s, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children (VFC) program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under provisions of the Affordable Care Act, section 2713 of the Public Health Service Act, immunization recommendations of the ACIP that have been approved by the Director of the Centers for Disease Control and Prevention and appear on CDC immunization schedules must be covered by applicable health plans.
Public Participation
Interested persons or organizations are invited to participate by submitting written views, recommendations, and data. Please note that comments received, including attachments and other supporting materials, are part of the public record and are subject to public disclosure. Comments will be posted on
www.regulations.gov.
Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. CDC will carefully review and consider all comments submitted to the docket.
Oral Public Comment:
This meeting will include time for members of the public to make an in-person oral comment. Oral public comment will occur before any scheduled votes including all votes relevant to the ACIP's Affordable Care Act and Vaccines for Children Program roles. Priority will be given to individuals who submit a request to make an oral public comment before the meeting according to the procedures below. On-site, in-person registration for oral public comment at the meeting will only be available if there is time remaining in the oral public comment session after all individuals who submitted a request to make an oral comment before the meeting have had an opportunity to speak. There is no guarantee there will be an opportunity for on-site, in-person registration for oral public comment, and all individuals interested in requesting to make an oral public comment are strongly encouraged to submit a request according to the instructions below.
Procedure for Oral Public Comment:
All persons interested in making an oral public comment at the June ACIP meeting must submit a request at
www.cdc.gov/vaccines/acip/meetings/
no later than 11:59 p.m., EDT, June 12, 2019 according to the instructions provided.
If the number of persons requesting to speak is greater than can be reasonably accommodated during the scheduled time, CDC will conduct a lottery to determine the speakers for each scheduled public comment session. CDC staff will notify individuals regarding their request to speak by email by June 14, 2019. To accommodate the significant interest in participation in the oral public comment session of ACIP meetings, each speaker will be limited to 3 minutes, and each speaker may only speak once per meeting.
Written Public Comment:
Written comments must be received on or before June 29, 2019.
Matters To Be Considered:
The agenda will include discussions on human papillomavirus vaccines, pneumococcal vaccines, influenza vaccines, meningococcal vaccines, hepatitis A vaccines, combination vaccines (diphtheria, tetanus, and pertussis; Haemophilus influenzae type b, hepatitis B, polio) dengue vaccine, pertussis vaccines, and herpes zoster vaccine. A recommendation vote is scheduled for human papillomavirus vaccines, pneumococcal vaccines, influenza vaccines, meningococcal vaccines, and hepatitis vaccines. A Vaccines for Children recommendation vote is scheduled for diphtheria, tetanus, and pertussis vaccines,
Haemophilus influenzae
type b vaccines, polio vaccines, hepatitis B vaccines, influenza vaccines, meningococcal vaccines, and hepatitis A vaccines. Agenda items are subject to change as priorities dictate. For more information on the meeting agenda visit
www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign
Federal Register
notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
regulations.gov